+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Dried Blood Spot Collection Cards Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337148
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Dried blood spot collection cards are accelerating modern diagnostic workflows by enabling decentralized, efficient, and minimally invasive sample collection. Senior decision-makers increasingly see these cards as essential for scalable, patient-centric healthcare delivery and improved operational effectiveness.

Market Snapshot: Dried Blood Spot Collection Cards Market Growth

The dried blood spot collection cards market expanded from USD 384.31 million in 2024 to USD 405.41 million in 2025, reflecting strong industry momentum across clinical diagnostics and public health initiatives. With a compound annual growth rate of 5.59%, projections indicate the market will reach USD 532.83 million by 2030. Strategic growth drivers include increasing market demand for diagnostic accuracy, expanding regulatory acceptance, and the integration of these cards into digital healthcare workflows. Industry leaders are responding with proven solutions that support changing testing needs while meeting the requirements for decentralized and patient-focused diagnostics.

Scope & Segmentation: Strategic Market Analysis

This research delivers a comprehensive evaluation of the dried blood spot collection cards market, offering actionable insights for decision-makers seeking clarity in a complex and evolving sector. The study includes in-depth analysis on major product lines, technological advancements, and strategic market segments:

  • Product Types: Filter paper cards and polymer coated cards, each supporting different levels of sample stability and suitability for a range of diagnostic workflows.
  • Technology: Advanced DBS cards and standard DBS cards, enabling laboratories and clinics to match technology solutions to sensitivity and application requirements.
  • Sample Types: Plasma spots, serum spots, and whole blood spots, meeting analytical needs for both screening and confirmatory testing protocols.
  • Applications: Clinical diagnostics, disease surveillance, forensic toxicology, newborn screening (covering congenital hypothyroidism, cystic fibrosis, phenylketonuria), and therapeutic drug monitoring, ensuring broad adoption in critical health domains.
  • End Users: Diagnostic laboratories, home care settings, hospitals and clinics, and research institutes, reflecting the full spectrum of healthcare delivery models.
  • Distribution Channels: Direct sales and distributors/wholesalers, tailored to organizational procurement preferences in different markets.
  • Geographies: Analysis spans Americas, Europe, Middle East & Africa, and Asia-Pacific, offering region- and country-level insights including key markets such as North America and Asia-Pacific.
  • Company Coverage: Profiles of over 20 innovative companies, highlighting leadership in R&D, manufacturing, and strategic partnerships within the industry.

Key Takeaways: Expert Insights for Decision-Makers

  • Transition to polymer-coated dried blood spot collection cards is enabling higher sensitivity in diagnostics by improving sample stability and analyte recovery in demanding clinical settings.
  • Integration with digital health and telemedicine platforms is strengthening patient management and remote monitoring, supporting continuity of care and facilitating decentralized workflows.
  • Regulatory authorities are broadening acceptance of dried blood spot methodologies, especially in newborn screening and infectious disease programs, which is catalyzing wider clinical uptake.
  • Decentralized sampling and home-based collection are extending diagnostic reach, supporting patient-centric approaches and enhancing healthcare access across varied resource environments.
  • Collaboration between technology vendors, healthcare providers, and laboratories is advancing compatibility with mass spectrometry and reinforcing process integration.
  • Growth in eco-friendly packaging and adoption of recyclable materials is distinguishing market participants focused on sustainability and corporate responsibility.

Tariff Impact: Adapting to U.S. Tariff Changes

The 2025 U.S. tariff revisions have driven significant supply chain adjustments in the dried blood spot card sector. Increased duties on raw materials, such as specialty filter paper and polymers, are prompting manufacturers to revise sourcing strategies. Many organizations are moving toward regional manufacturing centers and pursuing new supplier partnerships to counteract rising costs and procurement challenges. These measures, alongside ongoing industry policy advocacy, are resulting in a more resilient and regionally diversified supply network.

Methodology & Data Sources

This analysis is built on a mixed-methods research approach, utilizing over 30 primary expert interviews, structured surveys, and extensive secondary sources—including regulatory, patent, and industry reports. Stringent data triangulation and validation by a global advisory group support the reliability of findings, while advanced quantitative methods highlight market trends and pinpoint emerging opportunities.

Why This Report Matters: Strategic Value for Senior Leaders

  • Enables informed investment and procurement strategies through detailed segment analysis and technology adoption insights relevant to operational excellence.
  • Guides commercial teams to opportunities in home care, digital diagnostics, and sustainable manufacturing—areas driving future growth and differentiation.
  • Supports supply chain risk mitigation and agile response to changing tariff and sourcing conditions, providing clarity amid evolving market dynamics.

Conclusion

The dried blood spot collection cards market is positioned for sustained advancement, driven by innovation, regulatory progress, and digital transformation. Stakeholders leveraging these market insights can enhance resilience and capture new opportunities in diagnostics delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Adoption of automated sample punching systems enhancing throughput efficiency in dried blood spot workflows
5.2. Partnerships between diagnostic laboratories and card manufacturers accelerating bespoke dried blood spot solutions
5.3. Rising focus on remote patient monitoring and decentralized clinical trials driving dried blood spot adoption
5.4. Integration of automation workflows enhances throughput in dried blood spot processing labs
5.5. Rise of point-of-care diagnostics drives demand for user-friendly dried blood spot cards
5.6. Expansion of neonatal screening programs boosts requirements for standardized dried blood spot collection cards
5.7. Telehealth expansion drives surge in at-home dried blood spot collection card adoption
5.8. Sustainable and biodegradable card materials reducing environmental impact in diagnostics
5.9. AI-powered analytics platforms optimizing data interpretation from dried blood spot samples
5.10. Advancements in microfluidic technologies to enhance blood sample accuracy on filter cards
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Dried Blood Spot Collection Cards Market, by Product Type
8.1. Filter Paper Cards
8.2. Polymer Coated Cards
9. Dried Blood Spot Collection Cards Market, by Technology
9.1. Advanced DBS Cards
9.2. Standard DBS Cards
10. Dried Blood Spot Collection Cards Market, by Sample Type
10.1. Plasma Spots
10.2. Serum Spots
10.3. Whole Blood Spots
11. Dried Blood Spot Collection Cards Market, by Application
11.1. Clinical Diagnostics
11.2. Disease Surveillance
11.3. Forensic Toxicology
11.4. Newborn Screening
11.4.1. Congenital Hypothyroidism
11.4.2. Cystic Fibrosis Screening
11.4.3. Phenylketonuria
11.5. Therapeutic Drug Monitoring
12. Dried Blood Spot Collection Cards Market, by End User
12.1. Diagnostic Laboratories
12.2. Home Care Settings
12.3. Hospitals & Clinics
12.4. Research Institutes
13. Dried Blood Spot Collection Cards Market, by Distribution Channel
13.1. Direct Sales
13.2. Distributors & Wholesalers
14. Dried Blood Spot Collection Cards Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Dried Blood Spot Collection Cards Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Dried Blood Spot Collection Cards Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Ahlstrom Oyj
17.3.2. ARCHIMEDlife GmbH by amedes Holding GmbH
17.3.3. BioIVT LLC
17.3.4. Cambrian Biotech Pvt. Ltd.
17.3.5. Capitainer AB
17.3.6. CENTOGENE GmbH
17.3.7. Chemie-Erzeugnisse und Adsorptionstechnik AG
17.3.8. Eastern Business Forms, Inc
17.3.9. F. Hoffmann-La Roche Ltd.
17.3.10. Huachenyang (Shenzhen) Technology Co., Ltd
17.3.11. Inotiv, Inc.
17.3.12. Kala Scientific INC.
17.3.13. Merck KGaA
17.3.14. Monobind Inc.
17.3.15. QIAGEN N.V.
17.3.16. RDA Spot Inc
17.3.17. Salimetrics, LLC.
17.3.18. Shimadzu Corporation
17.3.19. Tianjin Geneally Biotechnology Co., Ltd.
17.3.20. DBS System SA
17.3.21. OmegaQuant Analytics, LLC
17.3.22. ADVANTEC MFS, INC.
17.3.23. Telimmune LLC
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Dried Blood Spot Collection Cards market report include:
  • Ahlstrom Oyj
  • ARCHIMEDlife GmbH by amedes Holding GmbH
  • BioIVT LLC
  • Cambrian Biotech Pvt. Ltd.
  • Capitainer AB
  • CENTOGENE GmbH
  • Chemie-Erzeugnisse und Adsorptionstechnik AG
  • Eastern Business Forms, Inc
  • F. Hoffmann-La Roche Ltd.
  • Huachenyang (Shenzhen) Technology Co., Ltd
  • Inotiv, Inc.
  • Kala Scientific INC.
  • Merck KGaA
  • Monobind Inc.
  • QIAGEN N.V.
  • RDA Spot Inc
  • Salimetrics, LLC.
  • Shimadzu Corporation
  • Tianjin Geneally Biotechnology Co., Ltd.
  • DBS System SA
  • OmegaQuant Analytics, LLC
  • ADVANTEC MFS, INC.
  • Telimmune LLC

Table Information